TNFSF8 Anticorps
(Tumor Necrosis Factor (Ligand) Superfamily, Member 8 (TNFSF8))
Choisissez l’un des 67 anticorps TNFSF8 de notre liste de produits basés sur 3 publications et 27 images de validation.
Découvrez des anticorps TNFSF8 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de TNFSF8 dans plusieurs espèces, y compris Human, Mouse, Rat, Cow, Horse, Bat, Dog, Guinea Pig, Rabbit, et prend en charge diverses applications de recherche telles que WB, FACS, IHC, ELISA, IF.
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants TNFSF8, issus de différents hôtes tels que Rabbit, Mouse, Rat. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de TNFSF8 sont Tnfsf8, TNFSF8.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| TNFSF8 anticorps (APC) | Humain | Lapin Polyclonal |
|
1.196,07 €
Voir le prix
|
|
| TNFSF8 anticorps (PE) | Humain | Lapin Polyclonal |
|
1.029,23 €
Voir le prix
|
|
| TNFSF8 anticorps (AA 63-234) (Cy3) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| TNFSF8 anticorps (AA 63-234) (FITC) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| TNFSF8 anticorps (AA 63-234) (Fluoro594) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| TNFSF8 anticorps (AA 63-234) (Fluoro647) | Humain | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
|
| TNFSF8 anticorps (AA 63-234) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- APC
- Isotype
- IgG
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- AA 63-234
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 63-234
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro594
- Isotype
- IgG
- Epitope
- AA 63-234
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- AA 63-234
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- AA 63-234
Dernières publications pour nos TNFSF8 Anticorps
: "Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30- Tumors." dans: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 27, Issue 10, pp. 1825-1835, (2019) (PubMed).
: "CD117⁺ CD3⁻ CD56⁻ OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues." dans: European journal of immunology, Vol. 41, Issue 6, pp. 1563-72, (2011) (PubMed).
: "Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1." dans: The EMBO journal, Vol. 26, Issue 13, pp. 3086-97, (2007) (PubMed).
: "CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes." dans: The Journal of clinical investigation, Vol. 116, Issue 9, pp. 2366-77, (2006) (PubMed).
: "Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis." dans: The Journal of experimental medicine, Vol. 191, Issue 2, pp. 375-80, (2000) (PubMed).
: "High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus." dans: Blood, Vol. 91, Issue 9, pp. 3323-32, (1998) (PubMed).
: "CD30-mediated signaling promotes the development of human T helper type 2-like T cells." dans: The Journal of experimental medicine, Vol. 182, Issue 6, pp. 1655-61, (1996) (PubMed).
: "CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF." dans: Cell, Vol. 73, Issue 7, pp. 1349-60, (1993) (PubMed).
: "CD117⁺ CD3⁻ CD56⁻ OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues." dans: European journal of immunology, Vol. 41, Issue 6, pp. 1563-72, (2011) (PubMed).
: "Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1." dans: The EMBO journal, Vol. 26, Issue 13, pp. 3086-97, (2007) (PubMed).
: "CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes." dans: The Journal of clinical investigation, Vol. 116, Issue 9, pp. 2366-77, (2006) (PubMed).
: "Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis." dans: The Journal of experimental medicine, Vol. 191, Issue 2, pp. 375-80, (2000) (PubMed).
: "High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus." dans: Blood, Vol. 91, Issue 9, pp. 3323-32, (1998) (PubMed).
: "CD30-mediated signaling promotes the development of human T helper type 2-like T cells." dans: The Journal of experimental medicine, Vol. 182, Issue 6, pp. 1655-61, (1996) (PubMed).
: "CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF." dans: Cell, Vol. 73, Issue 7, pp. 1349-60, (1993) (PubMed).
Pseudonymes pour TNFSF8 Anticorps
tumor necrosis factor (ligand) superfamily, member 8 (Tnfsf8) AnticorpsTNF superfamily member 8 (TNFSF8) Anticorps
tumor necrosis factor superfamily member 8 (TNFSF8) Anticorps
TNF superfamily member 8 (Tnfsf8) Anticorps
Cd30l Anticorps
CD30L Anticorps
CD30LG Anticorps
CD153 Anticorps
TNFRSF8 Anticorps
TNFSF8 Anticorps
Avez-vous cherché autre chose?
- TNFSF4 Anticorps
- TNFSF15 Anticorps
- TNFSF14 Anticorps
- TNFSF13 Anticorps
- TNFRSF8 Anticorps
- TNFRSF6B Anticorps
- TNFRSF4 Anticorps
- TNFRSF21 Anticorps
- TNFRSF1B Anticorps
- TNFRSF1A Anticorps
- TNFRSF19 Anticorps
- TNFRSF18 Anticorps
- TNFRSF13C Anticorps
- TNFRSF12A Anticorps
- TNFRSF11A Anticorps
- TNFRSF10A Anticorps
- TNFAIP8 Anticorps
- TNFAIP6 Anticorps
- TNFAIP3 Anticorps
- TNFAIP2 Anticorps
- TNFSF9 Anticorps
- TNIP1 Anticorps
- TNIP2 Anticorps
- TNIP3 Anticorps
- TNK1 Anticorps
- TNK2 Anticorps
- TNKS Anticorps
- TNKS1BP1 Anticorps
- TNKS2 Anticorps
- TNMD Anticorps
- TNNC2 Anticorps
- TNNI1 Anticorps
- TNNI1 Anticorps
- TNNI2 Anticorps
- TNNI3 Anticorps
- TNNI3K Anticorps
- TNNT3 Anticorps
- TNP1 Anticorps
- TNP2 Anticorps
- TNPO2 Anticorps
Vous êtes ici:
